Drug Trial Radar · NCT01522976
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
282
Actual
Start
Mar 1, 2012
Primary completion
Jun 1, 2015
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Feb 1, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.
Conditions
- Chronic Myelomonocytic Leukemia
- Chronic Myelomonocytic Leukemia-1
- Chronic Myelomonocytic Leukemia-2
- Myelodysplastic Syndrome
- Myelodysplastic Syndrome With Excess Blasts
- Myelodysplastic Syndrome With Excess Blasts-1
- Myelodysplastic Syndrome/Acute Myeloid Leukemia
Interventions
AzacitidineDrug
Given SC or IV
Laboratory Biomarker AnalysisOther
Correlative studies
LenalidomideDrug
Given PO
VorinostatDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response Rate (Phase II)Time frame: Up to 5 years
- Overall Survival (Phase III)Time frame: Up to 5 years
Locations
294 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama
Mayo Clinic in Arizona
Scottsdale, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
John L McClellan Memorial Veterans Hospital
Little Rock, Arkansas
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
City of Hope Comprehensive Cancer Center
Duarte, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
Kaiser Permanente-Oakland
Oakland, California
Stanford Cancer Institute Palo Alto
Palo Alto, California
Kaiser Permanente-Richmond
Richmond, California
Kaiser Permanente-South Sacramento
Sacramento, California
Kaiser Permanente Sacramento Medical Center
Sacramento, California
Kaiser Permanente-San Francisco
San Francisco, California
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California
Kaiser Permanente-San Rafael
San Rafael, California
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California
Kaiser Permanente-Santa Rosa
Santa Rosa, California
Sutter Pacific Medical Foundation
Santa Rosa, California
Kaiser Permanente-South San Francisco
South San Francisco, California
Kaiser Permanente-Vallejo
Vallejo, California
Kaiser Permanente-Walnut Creek
Walnut Creek, California
The Medical Center of Aurora
Aurora, Colorado
UCHealth University of Colorado Hospital
Aurora, Colorado
Boulder Community Foothills Hospital
Boulder, Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
AdventHealth Porter
Denver, Colorado
Colorado Blood Cancer Institute
Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado
Rocky Mountain Cancer Centers-Midtown
Denver, Colorado
Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado
Rocky Mountain Cancer Centers-Rose
Denver, Colorado
Rose Medical Center
Denver, Colorado
Western States Cancer Research NCORP
Denver, Colorado
Mercy Medical Center
Durango, Colorado
Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado
Swedish Medical Center
Englewood, Colorado
Poudre Valley Hospital
Fort Collins, Colorado
Mountain Blue Cancer Care Center
Golden, Colorado
Showing 40 of 294 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.